AFC Agro Biotech Limited (DSE:AFCAGRO)

-38.13% (1Y)

Market Cap	944.77M
Revenue (ttm)	434.50M
Net Income (ttm)	799.87K
Shares Out	115.22M
EPS (ttm)	0.01
PE Ratio	1,181.15
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	158,780
Average Volume	74,311
Open	8.30
Previous Close	8.20
Day's Range	8.30 - 8.60
52-Week Range	7.20 - 15.70
Beta	-0.21
RSI	63.92
Earnings Date	Dec 24, 2025

About AFC Agro Biotech

AFC Agro Biotech Limited engages in the manufacture and sale of bio-pharmaceuticals and bio-chemical products in Bangladesh. The company produces various products for the pharma, food, and textile sectors from agricultural raw materials, such as corn starch, potato starch, molasses, AFCABL, and other nutrients. It also offers Erythromycin, a macrolide antibiotic that is used for people who have an allergy to penicillin, and for respiratory tract infections; L-Lysine, an amino acid for building block protein in the body; and acetic acid, a chemi...

• Industry: Medicinal Chemicals and Botanical Products
• Founded: 2010
• Employees: 181
• Stock Exchange: Dhaka Stock Exchange
• Ticker Symbol: AFCAGRO

Financial Performance

In 2022, AFC Agro Biotech's revenue was 701.88 million, an increase of 55.07% compared to the previous year's 452.64 million. Earnings were 25.63 million, an increase of 45.27%.